Taylor PC, Takeuchi T, Burmester GR, Durez P, et al. Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. Ann Rheum Dis 2021 Oct 27. pii: annrheumdis-2021-221276.
PMID: 34706874